Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000129088.49276.83PMID 15123523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo.

  2004cited by this paper
• Expression and Cellular Localisation of Renal Endothelin-1 and Endothelin Receptor Subtypes in Autosomal-Dominant Polycystic Kidney Disease

  2003cited by this paper
• Expansive Arterial Remodeling Is Associated With Increased Neointimal Macrophage Foam Cell Content: The Murine Model of Macrophage-Rich Carotid Artery Lesions

  2002cited by this paper
• Targeted Disruption of the Matrix Metalloproteinase-9 Gene Impairs Smooth Muscle Cell Migration and Geometrical Arterial Remodeling

  2002cited by this paper
• Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

  2002cited by this paper
• Nuclear medicine applications in molecular imaging

  2002cited by this paper
• Matrix metalloproteinases: a tail of a frog that became a prince

  2002cited by this paper
• Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

  2002cited by this paper
• Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

  2002cited by this paper
• In vivo molecular target assessment of matrix metalloproteinase inhibition

  2001cited by this paper
• Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse.

  2001cited by this paper
• Development of matrix metalloproteinase inhibitors in cancer therapy.

  2001cited by this paper
• Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.

  1997cited by this paper
• Mutational Study of the Amino-terminal Domain of Human Tissue Inhibitor of Metalloproteinases 1 (TIMP-1) Locates an Inhibitory Region for Matrix Metalloproteinases*

  1997cited by this paper
• Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

  1995cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Preparation of 17-amino-22-(4′-azido-3′-125iodophenacyl)-17-demethoxygeldanamycin (1): An ansamycin for photoaffinity labeling

  1994cited by this paper
• An efficient and selective method for the preparation of iodophenols

  1990cited by this paper
• This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba

  year unknowncited by this paper

• Molecular imaging of cardiovascular disease: Current status and future perspective.

  2025cites this paper
• Multi-Scale Imaging of Vascular Pathologies in Cardiovascular Disease

  2022cites this paper
• Advances in positron emission tomography tracers related to vascular calcification

  2022cites this paper
• Vulnerable Plaque Imaging.

  2022cites this paper
• Selective Imaging of Matrix Metalloproteinase-13 to Detect Extracellular Matrix Remodeling in Atherosclerotic Lesions

  2021cites this paper
• Molecular Imaging of Atherosclerosis

  2021cites this paper
• Towards Optimized Bioavailability of 99mTc-Labeled Barbiturates for Non-invasive Imaging of Matrix Metalloproteinase Activity

  2021cites this paper
• Imaging Inflammation in Patients and Animals: Focus on PET Imaging the Vulnerable Plaque

  2021cites this paper
• Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque

  2020cites this paper
• Carotid Plaque Imaging with SPECT/CT and PET/CT

  2020cites this paper
• Validation de modalités d’imagerie innovantes de l’athérosclérose par cathéter intravasculaire bimodal combinant fluorescence (NIRF) et ultrasons (IVUS) couplé à l’injection locale de sondes moléculaires in vivo ciblant ICAM-1 et le collagène

  2019cites this paper
• Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs)

  2019cites this paper
• Current and Future Cardiovascular PET Radiopharmaceuticals.

  2019cites this paper
• Advances in cardiovascular imaging

  2019cites this paper
• Molecular Imaging of Vulnerable Plaque.

  2018cites this paper
• Chemical Tools for Selective Activity Profiling of Endogenously Expressed MMP-14 in Multicellular Models.

  2018cites this paper
• Antibody‐Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases

  2018cites this paper
• Synthesis and PreliminaryIn VitroandIn VivoEvaluation of Thiirane‐Based Slow‐Binding MMP Inhibitors as Potential Radiotracers for PET Imaging

  2018cites this paper
• Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.

  2018cites this paper
• Evaluation of [68Ga]Ga-DOTA-TCTP-1 for the Detection of Metalloproteinase 2/9 Expression in Mouse Atherosclerotic Plaques

  2018cites this paper
• Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis.

  2017cites this paper
• A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque

  2017cites this paper
• MMP-12 activity during vascular remodelling

  2017cites this paper
• Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective

  2017cites this paper
• Advanced vascular imaging: Technical and clinical applications in type 2 diabetes

  2017cites this paper
• Molecular imaging of the extracellular matrix in the context of atherosclerosis.

  2017cites this paper
• Pathophysiological Aspects of Proteases

  2017influential citation
• Matrix Metalloproteinases (MMPs) in Cancer Initiation and Progression

  2017cites this paper
• Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.

  2017cites this paper
• Potential of 7-nAChR PET Imaging in Atherosclerosis

  2017cites this paper
• Preclinical Evaluation of RYM1, a Matrix Metalloproteinase–Targeted Tracer for Imaging Aneurysm

  2017cites this paper
• Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases

  2017cites this paper
• Molecular targets in aortic aneurysm for establishing novel management paradigms.

  2017cites this paper
• Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.

  2016cites this paper
• Inflammation-targeted gold nanorods for intravascular photoacoustic imaging detection of matrix metalloproteinase-2 (MMP2) in atherosclerotic plaques.

  2016cites this paper
• Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke

  2015cites this paper
• Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques

  2015cites this paper
• Modélisation, simulation et quantification de lésions athéromateuses en tomographie par émission de positons. (Numerical modeling, simulation and quantification of atheromatous lesions in positron emission tomography)

  2015cites this paper
• Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis.

  2015cites this paper
• Development and preclinical comparison of two non- peptidomimetic MMP/ADAM inhibitors for PET

  2015cites this paper
• Évaluation de ligands pour l’imagerie moléculaire de la néoangiogenèse tumorale

  2015cites this paper
• Vasa Vasorum in Atherosclerosis and Clinical Significance

  2015cites this paper
• Design, (radio)synthesis and applications of radiolabelled matrix metalloproteinase inhibitors for PET

  2015cites this paper
• 1.10 – High-Resolution Small Animal Imaging

  2014cites this paper
• Targeting P-Selectin by Gallium-68–Labeled Fucoidan Positron Emission Tomography for Noninvasive Characterization of Vulnerable Plaques: Correlation With In Vivo 17.6T MRI

  2014cites this paper
• Development of an aptamer-conjugated fluorescent nanoprobe for MMP2

  2014cites this paper
• A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging.

  2014cites this paper
• Molecular Imaging of the Cardiac Extracellular Matrix

  2014cites this paper
• Modern imaging techniques of vulnerable atherosclerotic plaque on coronary arteries

  2014cites this paper
• Integration of Biomarkers with Plaque Imaging

  2014cites this paper
• Single-photon emission computed tomography tracers for predicting and monitoring cancer therapy.

  2014cites this paper
• Visualizing the atherosclerotic plaque: a chemical perspective.

  2014cites this paper
• Molecular imaging of plaques in coronary arteries with PET and SPECT

  2014cites this paper
• Molecular Pathogenesis of Fibulin-4 Associated Aortic Aneurysms

  2014cites this paper
• 10.5937/mckg48-3912 = Modern imaging techniques of vulnerable atherosclerotic plaque on coronary arteries

  2014cites this paper
• Emergence of molecular imaging of aortic aneurysm: Implications for risk stratification and management

  2014cites this paper
• Imaging Neuroinflammation – from Bench to Bedside

  2014influential citation
• Applications of Molecular Small-Animal Imaging in Cardiology

  2014cites this paper
• Myocardial Infarction Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After

  2013cites this paper
• Nanotechnology and Cardiovascular Diseases

  2013cites this paper
• Imaging macrophage development and fate in atherosclerosis and myocardial infarction

  2013cites this paper
• Molecular Imaging of Atherosclerosis

  2013cites this paper
• University of Groningen Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT Matusiak,

  2013cites this paper
• Probes for non-invasive matrix metalloproteinase-targeted imaging with PET and SPECT.

  2013cites this paper
• Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.

  2013cites this paper
• In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences

  2013cites this paper
• Preclinical Imaging: an Essential Ally in Modern Biosciences

  2013cites this paper
• PET Imaging of Inflammation Biomarkers

  2013cites this paper
• In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE-/-mice using VCAM-1-Specific , 99 m Tc-Labeled Peptidic Sequences

  2013cites this paper
• Caractérisation et imagerie moléculaire de la plaque d'athérome : études pré-cliniques

  2013cites this paper
• Ultra-high-resolution quantitative multi-pinhole small-animal SPECT

  2013cites this paper
• Near-infrared fluorescent imaging of matrix metalloproteinase activity following myocardial infarction

  2013cites this paper
• Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice.

  2013cites this paper
• Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.

  2013cites this paper
• Vascular Extracellular Matrix in Atherosclerosis

  2013cites this paper
• Stroma Targeting Nuclear Imaging and Radiopharmaceuticals

  2012cites this paper
• Molecular Imaging in Cardiovascular Disease

  2012cites this paper
• Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.

  2012cites this paper
• DETECTION OF THE VULNERABLE ATHEROSCLEROTIC PLAQUE

  2012cites this paper
• Non-FDG imaging of atherosclerosis: Will imaging of MMPs assess plaque vulnerability?

  2012cites this paper
• Multimodality imaging in interventional cardiology

  2012cites this paper
• Multimodality imaging in interventional

  2012cites this paper
• PET Imaging of the Cardiovascular System in Drug Development: Status and Vision

  2012cites this paper
• Molecular and Cellular Targets of the MRI Contrast Agent P 947 for Atherosclerosis Imaging

  2012cites this paper
• Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

  2012cites this paper
• Molecular Imaging of Vascular Inflammation, Atherosclerosis, and Thrombosis

  2012cites this paper
• 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors

  2012cites this paper
• CHAPTER 1 Imaging of Atherosclerosis ; Invasive and Non-invasive Techniques

  2012cites this paper
• Pharmacomodulation of Broad Spectrum Matrix Metalloproteinase Inhibitors Towards Regulation of Gelatinases

  2012cites this paper
• A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.

  2012cites this paper
• A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.

  2012cites this paper
• Molecular Imaging of Cardiovascular Disease

  2012cites this paper
• Noninvasive Targeting of Vulnerable Carotid Plaques for Therapeutic Interventions

  2011cites this paper
• Pathophysiology of atherosclerosis: the role of inflammation.

  2011cites this paper
• Non-invasive detection of vulnerable coronary plaque.

  2011cites this paper
• The year in cardiac imaging.

  2011cites this paper
• Matrix Metalloproteinase Activation Predicts Amelioration of Remodeling After Dietary Modification in Injured Arteries

  2011cites this paper
• Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata

  2011cites this paper
• Development of molecular techniques for imaging and treatment of tumors.

  2011cites this paper
• The MMP inhibitor (R)-2-(N-benzyl-4-(2-[18F]fluoroethoxy)phenylsulphonamido)-N-hydroxy-3-methylbutanamide: Improved precursor synthesis and fully automated radiosynthesis.

  2011cites this paper